Secretos y mentiras en una startup de Silicon Valley
In 2014, Theranos founder and CEO Elizabeth Holmes was regarded as the new Steve Jobs: a brilliant Stanford drop-out student whose magical new company promised to revolutionize the medical industry with a machine, the Edison, that would test blood significantly faster and easier. Backed by investors like Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $ 9 billion. There was only one problem: the technology was not working. For years, Holmes had misled investors, FDA officials, and her own employees. When John Carreyrou, a Wall Street Journal reporter, received a tip from a former Theranos employee and began asking questions, both he and the newspaper were threatened with lawsuits. Still, they published the first of numerous articles on Theranos in late 2015. By early 2017, the company's value was zero and Holmes was facing...read more
